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We were very pleased that our finding of an association between coronavirus disease 2019 
(COVID-19) outcome in China and selenium status (1) was endorsed by Seale and colleagues, 
based on their understanding of the likely mechanism by which severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) interacts with the selenoprotein, cytosolic glutathione 
peroxidase (GPX1) (2). 
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GPX1 is low in the hierarchy of selenoprotein expression, hence, it is among the first 
selenoproteins to be depleted in selenium deficiency (3). However, not only does selenium 
deficiency reduce the activity of GPX1 but it also significantly compromises the activity or 
concentration of other selenoproteins, including GPX4, thioredoxin reductase 1–3, and 
SELENOS, which have antioxidant or anti-inflammatory roles that are important in combatting 
viral infection (4). Infection with respiratory viruses, such as SARS-CoV-2, induces the 
production of reactive oxygen species and disturbs the host's redox balance, triggering 
pronounced inflammation and subsequent tissue damage (5). Moreover, excessive oxidative 
stress, in the absence of adequate GPX1, causes mutation of the viral genome, leading to the 
emergence of more virulent strains (6). A variety of selenoproteins, in addition to GPX1, can 
counteract oxidative stress and inflammation, as provoked by SARS-CoV-2 (4). 
 
The relative importance of GPX1 in the context of COVID-19 warrants further consideration. 
Platelet GPX1 activity, a more sensitive marker of selenium status than plasma GPX, was 
measured in a cohort of 119 healthy UK volunteers with a baseline selenium intake of 55 µg/d 
(7). GPX1 activity did not change significantly on supplementation of the volunteers with 50, 
100, or 200 µg selenium/d, as selenium-yeast, over a period of 10 wk (P = 0.16), implying that 
an intake of 55 µg/d is sufficient to optimize GPX1 activity (7). We previously reported that the 
city of Enshi in Hubei province, with an intake of 550 µg/d, had a cure rate that was significantly 
higher than that of other Hubei cities (1). This implies the possible existence of a selenium-based 
mechanism or mechanisms for overcoming SARS-CoV-2 infection that are not solely based on 
optimization of selenoproteins and that may require a higher selenium intake, at least during the 
course of the infection. 
 
On a separate issue, echoing our findings for China (1), Seale and colleagues also commented on 
the substantial regional differences observed in the severity of patient outcomes and case-fatality 
rates elsewhere (2). This being the case, they suggest “probing for selenium concentrations 
among both symptomatic and asymptomatic SARS-CoV-2–infected individuals.” However, 
there is a problem in measuring selenium status by the usual methods of serum or plasma 
selenium in individuals who are already infected, as serum/plasma selenium concentration will 
fall as a result of the systemic inflammatory response (8). Erythrocyte selenium is not affected by 
inflammation and can be determined to give a reliable measure of selenium status (8). 
Alternatively, selenium can be measured in toenail clippings or hair, which will also not be 
affected by the inflammatory response, at least in the short term (9). 
 
Despite the difficulties in the measurement of selenium status in infected individuals, it is 
possible to get some idea of their likely selenium status by their habitual location, as exposure to 
selenium from the diet is quite variable across the world (10). China exhibits the largest regional 
difference between maximum and minimum intake in any country; it may have been that fact 
that enabled us to see a significant difference between Chinese cities with respect to selenium 
status and cure rate (1). Of course, it is important to bear in mind that dietary-intake data are only 
estimations and are recognized to be of variable quality and accuracy and also that selenium 
supplementation is common, especially in the West (Figure 1). 
Given those caveats, we are in agreement with Seale and colleagues in hoping that the link 
between selenoproteins, selenium species, and SARS-CoV-2 may be able to provide novel 
insights into mechanisms that will help us reduce the risk of infection and mortality from SARS-
CoV-2 and other coronaviruses that may threaten us in the future. If appropriate, the efficacy of 




FIGURE 1. Selenium intake in different countries. The figure is based on data published since 
2000, apart from the intake for Venezuela, which is pre-2000 but is included as the value is 
notably high. Where countries had >1 result, the highest values (dark grey) and the lowest values 
(pale grey) are shown. Where there was only 1 result or a median value, it is shown in medium 
grey. Dietary-intake data are recognized to be of variable quality and accuracy. Adapted from 
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